Company Quick10K Filing
Shire
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 922 $167,103
10-Q 2018-11-01 Quarter: 2018-09-30
10-Q 2018-07-31 Quarter: 2018-06-30
10-Q 2018-04-26 Quarter: 2018-03-31
10-K 2018-02-20 Annual: 2017-12-31
10-Q 2017-10-27 Quarter: 2017-09-30
10-Q 2017-08-03 Quarter: 2017-06-30
10-Q 2017-05-02 Quarter: 2017-03-31
10-K 2017-02-22 Annual: 2016-12-31
10-Q 2016-11-02 Quarter: 2016-09-30
10-Q 2016-08-05 Quarter: 2016-06-30
10-Q 2016-05-04 Quarter: 2016-03-31
10-K 2016-02-23 Annual: 2015-12-31
10-Q 2015-10-30 Quarter: 2015-09-30
10-Q 2015-07-30 Quarter: 2015-06-30
10-Q 2015-05-05 Quarter: 2015-03-31
10-K 2015-02-24 Annual: 2014-12-31
10-Q 2014-10-31 Quarter: 2014-09-30
10-Q 2014-08-01 Quarter: 2014-06-30
10-Q 2014-05-07 Quarter: 2014-03-31
10-K 2014-02-24 Annual: 2013-12-31
10-Q 2013-10-25 Quarter: 2013-09-30
10-Q 2013-08-01 Quarter: 2013-06-30
10-Q 2013-05-07 Quarter: 2013-03-31
10-K 2013-02-25 Annual: 2012-12-31
10-Q 2012-11-02 Quarter: 2012-09-30
10-Q 2012-08-06 Quarter: 2012-06-30
10-Q 2012-05-09 Quarter: 2012-03-31
10-K 2012-02-23 Annual: 2011-12-31
10-Q 2011-11-07 Quarter: 2011-09-30
10-Q 2011-08-08 Quarter: 2011-06-30
10-Q 2011-05-04 Quarter: 2011-03-31
10-Q 2010-08-09 Quarter: 2010-06-30
10-Q 2010-05-06 Quarter: 2010-03-31
10-K 2010-02-26 Annual: 2009-12-31
8-K 2019-01-11 Other Events, Exhibits
8-K 2019-01-08 Leave Agreement, M&A, Shareholder Rights, Control, Officers, Amend Bylaw, Exhibits
8-K 2019-01-08 Other Events, Exhibits
8-K 2019-01-07 Other Events, Exhibits
8-K 2019-01-03 Other Events, Exhibits
8-K 2018-12-27 Other Events, Exhibits
8-K 2018-12-21 Other Events, Exhibits
8-K 2018-12-18 Other Events, Exhibits
8-K 2018-12-11 Other Events, Exhibits
8-K 2018-12-05 Other Events, Exhibits
8-K 2018-12-04 Shareholder Vote, Other Events, Exhibits
8-K 2018-11-29 Other Events, Exhibits
8-K 2018-11-22 Other Events, Exhibits
8-K 2018-11-21 Other Events, Exhibits
8-K 2018-11-09 Other Events, Exhibits
8-K 2018-11-02 Other Events, Exhibits
8-K 2018-11-01 Earnings, Exhibits
8-K 2018-10-30 Other Events, Exhibits
8-K 2018-10-24 Other Events, Exhibits
8-K 2018-10-18 Other Events, Exhibits
8-K 2018-10-11 Other Events, Exhibits
8-K 2018-10-05 Other Events, Exhibits
8-K 2018-10-04 Other Events, Exhibits
8-K 2018-09-26 Other Events, Exhibits
8-K 2018-09-20 Other Events, Exhibits
8-K 2018-09-14 Other Events, Exhibits
8-K 2018-09-10 Other Events, Exhibits
8-K 2018-09-10 Other Events, Exhibits
8-K 2018-09-10 Other Events, Exhibits
8-K 2018-09-03 Other Events, Exhibits
8-K 2018-08-31 Other Events, Exhibits
8-K 2018-08-29 Other Events, Exhibits
8-K 2018-08-24 Other Events, Exhibits
8-K 2018-08-23 Other Events, Exhibits
8-K 2018-08-21 Other Events, Exhibits
8-K 2018-08-14 Other Events, Exhibits
8-K 2018-08-07 Other Events, Exhibits
8-K 2018-08-01 Other Events, Exhibits
8-K 2018-07-31 Earnings, Exhibits
8-K 2018-07-26 Other Events, Exhibits
8-K 2018-07-20 Other Events, Exhibits
8-K 2018-07-16 Other Events, Exhibits
8-K 2018-07-09 Other Events, Exhibits
8-K 2018-07-02 Other Events, Exhibits
8-K 2018-06-26 Other Events, Exhibits
8-K 2018-06-19 Other Events, Exhibits
8-K 2018-06-13 Other Events, Exhibits
8-K 2018-06-07 Other Events, Exhibits
8-K 2018-06-01 Other Events, Exhibits
8-K 2018-05-28 Other Events, Exhibits
8-K 2018-05-21 Other Events, Exhibits
8-K 2018-05-16 Other Events, Exhibits
8-K 2018-05-15 Other Events, Exhibits
8-K 2018-05-11 Other Events, Exhibits
8-K 2018-05-08 Other Events, Exhibits
8-K 2018-05-08 Enter Agreement, Officers, Regulation FD, Exhibits
8-K 2018-05-04 Other Events, Exhibits
8-K 2018-05-03 Other Events, Exhibits
8-K 2018-05-02 Other Events, Exhibits
8-K 2018-05-01 Other Events, Exhibits
8-K 2018-04-27 Other Events, Exhibits
8-K 2018-04-26 Other Events, Exhibits
8-K 2018-04-26 Earnings, Exhibits
8-K 2018-04-25 Other Events, Exhibits
8-K 2018-04-23 Shareholder Vote, Other Events, Exhibits
8-K 2018-04-23 Other Events, Exhibits
8-K 2018-04-20 Other Events, Exhibits
8-K 2018-04-19 Other Events, Exhibits
8-K 2018-04-18 Other Events, Exhibits
8-K 2018-04-16 Other Events, Exhibits
8-K 2018-04-16 Regulation FD, Exhibits
8-K 2018-04-13 Other Events, Exhibits
8-K 2018-04-12 Other Events, Exhibits
8-K 2018-04-11 Other Events, Exhibits
8-K 2018-04-10 Other Events, Exhibits
8-K 2018-04-09 Other Events, Exhibits
8-K 2018-04-06 Other Events, Exhibits
8-K 2018-04-05 Other Events, Exhibits
8-K 2018-04-04 Other Events, Exhibits
8-K 2018-04-03 Other Events, Exhibits
8-K 2018-03-29 Other Events, Exhibits
8-K 2018-03-28 Other Events, Exhibits
8-K 2018-03-23 Other Events, Exhibits
8-K 2018-03-19 Other Events, Exhibits
8-K 2018-03-05 Other Events, Exhibits
8-K 2018-03-01 Other Events, Exhibits
8-K 2018-02-15 Other Events, Exhibits
8-K 2018-02-14 Earnings, Exhibits
8-K 2018-02-01 Other Events, Exhibits
8-K 2018-01-19 Other Events, Exhibits
8-K 2018-01-08 Regulation FD, Exhibits
8-K 2018-01-08 Regulation FD, Exhibits
8-K 2018-01-02 Other Events, Exhibits

Shire Financials

SHPG Metrics, Comps, Filings

Annual | Quarterly

Business

Shire plc and its subsidiaries (collectively referred to as either "Shire" or the "Company") is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions.

The Company has grown both organically and through acquisition, completing a series of major transactions that have brought therapeutic, geographic and pipeline growth and diversification. The Company will continue to conduct its own research and development (R&D) focused on rare diseases, as well as evaluate companies, products and pipeline opportunities that offer a strategic fit and have the potential to deliver value to all of the Company's stakeholders, including patients, physicians, policy makers, payers, partners, investors and employees.

Shire's mission is to develop and deliver breakthrough therapies for people around the world affected by rare diseases, and those with highly specialized conditions, who lack effective therapies to live their lives to the fullest.


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Annual)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Shire (SHPG) 167,103 17% 19.6 5% 97,348 37,430 15,702 2,714 5,227 9,077 177,968
Enel Generacion Chile (EOCC) 143,285 0% 3,669,228 1,671,737 0 0 0 0 143,285
Atreca (BCEL) 90,348 -5,033.4 -8% 227 8 0 0 -18 -18 90,193
Uber (UBER) 76,613 0% -12.1 -20% 30,980 15,072 6,265 0 -6,248 -5,579 67,526
Time Warner (TWX) 74,606 43% 9.5 8% 68,997 39,192 31,532 13,501 5,786 9,576 91,246
Aetna (AET) 66,578 49% 12.6 6% 57,103 38,540 61,233 30,264 3,690 5,387 67,966
Dell (DVMT) 60,080 30% 18.7 3% 115,520 111,401 91,601 27,175 3,386 5,498 102,737
Express Scripts (ESRX) 53,843 9% 9.4 9% 55,442 34,869 101,353 8,926 4,910 6,726 63,111
Praxair (PX) 47,321 0% 14.6 8% 19,979 13,229 12,037 0 1,508 3,763 54,918
SPDR Gold Trust (GLD) 35,933 9.6 10% 36,143 184 0 0 3,747 3,747 35,933
Brown Forman (BFB) 30,994 53% 27.8 15% 5,322 3,659 4,064 2,141 821 1,187 32,954
Woori Bank (WF) 29,676 0% 340,447,183 318,494,139 0 0 0 0 29,676
Hanwha Q Cells (HQCL) 29,263 0% 2,263 1,807 0 0 0 0 29,179
Rockwell Collins (COL) 23,197 75% 12.5 5% 19,026 11,919 8,665 6,467 1,032 1,803 22,459
Zoom Video (ZM) 23,039 81% 1,390.7 1% 1,070 326 268 216 8 16 22,823
Coca-Cola European Partners (CCE) 21,514 0% 18,216 11,652 0 0 0 0 21,235
Andeavor (ANDV) 19,940 11.4 8% 30,074 16,507 0 0 2,328 2,491 28,352
Lyft (LYFT) 18,822 33% -10.6 -31% 5,704 2,427 1,643 550 -1,783 -1,726 18,280
CA (CA) 18,329 0% 11.9 3% 13,103 5,201 4,009 0 409 1,507 17,903
Spectra Energy Partners (SEP) 17,408 0% 18.1 3% 22,411 10,409 2,104 0 697 1,402 25,407

Balance Sheet ($MM)2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-31
Cash49955162002,2390000
Accounts Receivable5986928458249611,0351,20103,010
Inventory19026034043745554563500
PP&E6778539329561,48483882800
Assets4,618007,3178,32313,632035,66240,941
Accounts Payable260208203248336912915
Long-Term Debt447022,96812,050
Liabilities2,7052,9363,1953,5082,957006,71414,142
Stockholders' Equity1,9123,80908,663028,94839
Income Statement ($MM)2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-31
Revenue2,6943,1283,9504,4074,7585,8306,10000
Cost of Revenue
Gross Profit
R&D6386627719669331,0681,56400
SG&A1,3431,5261,7512,1141,6512,0262,341600
Tax1381832861672902011464311
Net Income491588865826653,4061283273
Cash Flow ($MM)2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-31
Cash Operating627955681,38391113128-1377
Cash Investing-322-797-8090-361-4,0310-2,890-2,670
Cash Financing-29-58-68-244-345-113-1283,0272,664